Exploring the impact of neoadjuvant therapy on fluorescence-guided surgery for bone and soft tissue sarcomas: A narrative review

Résumé fourni par la source

Surgical resection is an important curative treatment for patients with bone and soft tissue sarcomas, often preceded by neoadjuvant therapy to reduce tumor size, enhance resectability and improve oncological outcomes. Fluorescence-guided surgery (FGS) has emerged as a promising technique to enhance intraoperative tumor visualization and resection precision. However, the impact of neoadjuvant therapy on the efficacy of FGS remains an area of ongoing investigation. This narrative review explores the current existing literature on the relationship between neoadjuvant therapies and the effectiveness of fluorescence-guided sarcoma surgery, identifying what has been learned from previous studies implementing FGS, and to hypothesize what is relevant for future studies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.